Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 2
2001 pubmed

Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model.

Koutrafouri. V V; Leondiadis. L L; Avgoustakis. K K; Livaniou. E E; Czarnecki. J J; Ithakissios. D S DS; Evangelatos. G P GP

Key Findings

  • Tα1 enhanced angiogenesis in the chick chorioallantoic membrane assay
  • Other thymosin peptides (Tβ10, Tβ9, ParaTα) inhibited angiogenesis
  • Increasing Tβ10 levels counteracted the pro‑angiogenic effect of Tβ4, showing dose‑dependent balance

Practical Outcomes

  • Tα1 could be considered for experimental use in wound‑healing or recovery protocols, but human dosing and safety are not established. The effective range in the study (ā‰ˆ0.016‑6.66 nmol in 10 µL) cannot be directly applied to people, so any trial should start with very low, cautious doses and monitor outcomes.

Summary

The study shows that thymosin alpha‑1 (Tα1) can boost new blood‑vessel growth in a chick embryo model, while some other thymosin peptides block this process. This suggests Tα1 might help with tissue repair, but the work is early‑stage and done in animals, not humans.

Abstract

The effect of alpha- and beta-thymosin peptides, namely prothymosin alpha (ProT(alpha)), thymosin alpha(1) (T(alpha)1), parathymosin alpha (ParaT(alpha)), thymosin beta(4) (Tbeta4), thymosin beta(10) (Tbeta10), and thymosin beta(9) (Tbeta9), on the angiogenesis process was investigated using the chick chorioallantoic membrane as an in vivo angiogenesis model. The thymosin peptides tested were applied in 10 microl aliquots containing 0.01-4 nmoles of Tbeta4, Tbeta10 or Tbeta9, 0.016-6.66 nmoles of T(alpha)1, 4.1 pmoles-1.66 nmoles of ProT(alpha), and 4.4 pmoles-1.76 nmoles of ParaT(alpha). Phorbol 12-myristate 13-acetate and hydrocortisone were also used as positive and negative control, respectively. Tbeta4, ProT(alpha) and T(alpha)1 were found to enhance angiogenesis, while Tbeta10, Tbeta9 and ParaT(alpha) exhibited an inhibitory effect on the angiogenesis process. When mixtures of Tbeta4 and Tbeta10 containing active amounts of the two peptides at different proportions were applied, the promoting effect of Tbeta4 on angiogenesis was reversed in the presence of increasing concentrations of Tbeta10 and vice versa. The effect of Tbeta10, Tbeta9, ProT(alpha) and ParaT(alpha), in parallel with Tbeta4 and T(alpha)1, on the angiogenesis process was investigated for the first time as far as we know and the results of this study offer more insight into the biological regulatory roles of thymosin peptides, and provide helpful information about their therapeutic potential. Whether these agents could be used either as inhibitors of angiogenesis in disease states where uncontrolled angiogenesis is involved, e.g. in carcinogenesis, or as angiogenesis promoters that could be useful in wound healing, fracture repair, peptic ulcers etc., remains to be further studied.

Study Information

Provider

pubmed

Year

2001

Date

2001-11-07T00:00:00.000Z

DOI

10.1016/s0304-4165(01)00200-8